Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sarah Demouche"'
Autor:
Andreea Calugareanu, Florian Specque, Sarah Demouche, Chloe Grolleau, Gabor Dobos, Marine Merandet, David Bergerat, Sandy Peltier, Marie Jachiet, Charles Cassius, Thibault Mahevas, Anne Saussine, Alexandre How-Kit, Rachel Onifarasoaniaina, Kevin Serror, Mylène Bohec, Sylvain Baulande, Clemence Lepelletier, Marc Mrad, Estelle Charvet, Adèle de Masson, David Boccara, Maxime Battistella, Hélène Le Buanec, Jean-David Bouaziz
Publikováno v:
Journal of Investigative Dermatology.
Autor:
Sarah Demouche, Thomas Bettuzzi, Emilie Sbidian, Delphine Laugier, Marie-Noelle Osmont, Saskia Ingen-Housz-Oro, Bénédicte Lebrun-Vignes
Publikováno v:
Therapies.
Background: Since the 2002 SCAR study, erythema multiforme(EM), a post-infectious disease, has been distinguished from Stevens-Johnson syndrome (SJS), drug-induced. Nevertheless, EM cases are still reported in the French pharmacovigilance database (F
Autor:
Sarah, Demouche, Pierre-Antoine, Juge, Pierre, Charles, Vincent, Descamps, Khadija, Benali, Florence, Brunet-Possenti
Publikováno v:
Dermatologic Therapy. 35
Autor:
Chloé Grolleau, Andreea Calugareanu, Sarah Demouche, Audrey Nosbaum, Delphine Staumont-Sallé, Hélène Aubert, Charles Cassius, Marie Jachiet, Anne Saussine, Martine Bagot, Hervé Bachelez, Maxime Battistella, Claire Hotz, Aurélie Du Thanh, Marie-Noëlle Crépy, David Bergerat, Marine Merandet, Rachel Onifarasoaniaina, Antonio Alberdi, Alexandre How-Kit, Jean-David Bouaziz, Hélène Le-Buanec
Publikováno v:
Journal of Investigative Dermatology. 143:711-721.e7
Dupilumab is a therapeutic antibody targeting IL-4 and IL-13 receptor subunit alpha used for the treatment of atopic dermatitis (AD) patients. Cases of psoriasis-like reactions induced under dupilumab treatment (DI-Pso) for AD were recently reported.
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A158
Introduction Depuis l’etude SCAR de 2002, l’erytheme polymorphe (EP) est distingue au plan clinique (cocardes) et physiopathologique (contexte post-infectieux) du syndrome de Stevens–Johnson (SJS, origine medicamenteuse). Il subsiste neanmoins